FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories Hydralazine HCl Tablets Recall

Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Av…

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · La Vergne, TN

Risk level
Class III
Reported by FDA
Nov 20, 2024
Recall ID
D-0045-2025
Check your lot numberHow we source this data

Summary

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalled Hydralazine HCl Tablets starting Nov 5, 2024. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0045-2025 on Nov 20, 2024. Reason: Failed Impurities/Degradation Specifications; during routine stability testing for impurities. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications; during routine stability testing for impurities.

Product description

Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.

Lot numbers, UPCs & expiration codes

Lot#: T04888, Exp 11/2024; T04946, Exp 12/2024; T04970, Exp 07/2025

Where it was sold

Nationwide in the US.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0045-2025
Classification
Class III
Status
Terminated
Recall initiated
Nov 5, 2024
FDA report date
Nov 20, 2024
Quantity
25814 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Original FDA data

Every field from FDA enforcement report D-0045-2025, exactly as published.

Show all FDA fields
City
La Vergne
State
TN
Status
Terminated
Country
United States
Event ID
95700
Address
341 Mason Rd
Code information
Lot#: T04888, Exp 11/2024; T04946, Exp 12/2024; T04970, Exp 07/2025
Postal code
37086-3606
Report date
Nov 20, 2024
Product type
Drugs
Recall number
D-0045-2025
Classification
Class III
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Product quantity
25814 tablets
Termination date
Sep 16, 2025
Reason for recall
Failed Impurities/Degradation Specifications; during routine stability testing for impurities.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.
Distribution pattern
Nationwide in the US.
Recall initiation date
Nov 5, 2024
Initial firm notification
Letter
Center classification date
Nov 14, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0045-2025, published Nov 20, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls